These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 26860621)
1. Indications for intubation and early tracheostomy in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Williams R; Hodge J; Ingram W Am J Surg; 2016 Apr; 211(4):684-688.e1. PubMed ID: 26860621 [TBL] [Abstract][Full Text] [Related]
2. Upper airway involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Bhullar HK; Aung AK; Graudins L; Ihle J; Gin D; Cleland H; Mei Teh B Burns; 2020 May; 46(3):682-686. PubMed ID: 31591001 [TBL] [Abstract][Full Text] [Related]
3. The use of porcine xenografts in patients with toxic epidermal necrolysis. Young JB; Gondek SP; Troche M; Summitt JB; Rae L; Thayer WP; Kahn SA Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163 [TBL] [Abstract][Full Text] [Related]
4. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome). Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073 [TBL] [Abstract][Full Text] [Related]
5. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents. Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222 [TBL] [Abstract][Full Text] [Related]
6. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience. Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855 [TBL] [Abstract][Full Text] [Related]
8. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN. Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392 [TBL] [Abstract][Full Text] [Related]
9. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; MaƮtre B Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174 [TBL] [Abstract][Full Text] [Related]
10. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness. Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613 [TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature. Ziemer M; Kardaun SH; Liss Y; Mockenhaupt M Br J Dermatol; 2012 Mar; 166(3):575-600. PubMed ID: 22014091 [TBL] [Abstract][Full Text] [Related]
12. The use of Biobrane Rogers AD; Blackport E; Cartotto R Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303 [TBL] [Abstract][Full Text] [Related]
13. Hospital management and clinical factors associated with ophthalmic involvement in toxic epidermal necrolysis. Hii BW; Mahar PD; Wasiak J; Hall AJ; Paul E; Marsh P; Buck DA; Cleland H Burns; 2014 Aug; 40(5):903-8. PubMed ID: 24286611 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260 [TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management. Sane SP; Bhatt AD J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928 [TBL] [Abstract][Full Text] [Related]
16. Managing respiratory complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Lee KCH; Ko JP; Oh CC; Sewa DW Int J Dermatol; 2022 Jun; 61(6):660-666. PubMed ID: 34494255 [TBL] [Abstract][Full Text] [Related]
17. Predicting Mechanical Ventilation and Mortality: Early and Late Indicators in Steven-Johnson Syndrome and Toxic Epidermal Necrolysis. Beck A; Cooney R; Gamelli RL; Mosier MJ J Burn Care Res; 2016; 37(1):e47-55. PubMed ID: 26594858 [TBL] [Abstract][Full Text] [Related]
18. Ventilatory support in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. Phan K; Oh LJ; Issler-Fisher A; Rao A; Wong EH; Maitz P J Dermatolog Treat; 2022 Feb; 33(1):525-530. PubMed ID: 32412819 [TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523 [TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience. Lalosevic J; Nikolic M; Gajic-Veljic M; Skiljevic D; Medenica L Int J Dermatol; 2015 Aug; 54(8):978-84. PubMed ID: 25385069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]